In the manufacturing of active pharmaceutical ingredients (API) and products there is a need to conduct qualitative and/or quantitative health-based risk assessments for occupational safety purposes. When performed from an occupational standpoint, qualitative health-based risk assessments involve the categorization (“banding”) of the API based on toxicity and potency, which provides a measure of relative hazard. Alternatively, quantitative occupational health-based risk assessments involve the development of Occupational Exposure Limits (OELs), “safe” or acceptable concentrations of contaminants in the air, which allow the contract manufacturing organization and/or the drug innovator to quantitatively assess worker exposure potential through industrial hygiene air monitoring. This webinar will provide a summary on the global landscape of occupational exposure risk assessment and highlight the differences between banding and calculating an OEL.

22 October 2024 | 11am EDT, 3pm GMT, 5pm CEST

By completing this form, you submit your information to the webinar organizer, who will use it to communicate with you regarding this event and their other services.